载脂蛋白C3(APOC3)重组蛋白
Recombinant Apolipoprotein C3 (APOC3)
Apo-C3; APOCIII; APOC-III
- 编号RPB890Hu01
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量38.8kDa
- 实际分子量34kDa(差异分析请参阅说明书)
- 片段与标签Ser21~Ala99 with N-terminal His and GST Tag
- 缓冲液成份100mM NaHCO3, 500mM NaCl缓冲液（pH8.3,含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性状冻干粉
- 纯度> 90%
- 等电点5.8
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 864 ¥ 2160 ¥ 4320 ¥ 12960 ¥ 32400
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
Figure . Gene Sequencing (extract)
-
Figure. SDS-PAGE
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| APB890Hu01 | 载脂蛋白C3(APOC3)活性蛋白 | Cell culture; Activity Assays. |
| RPB890Hu03 | 载脂蛋白C3(APOC3)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB890Hu02 | 载脂蛋白C3(APOC3)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB890Hu01 | 载脂蛋白C3(APOC3)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB890Hu01 | 载脂蛋白C3(APOC3)多克隆抗体 | WB; ICC; IHC-P; IHC-F; ELISA. |
| MAB890Hu22 | 载脂蛋白C3(APOC3)单克隆抗体 | WB; IHC; ICC; IP. |
| SEB890Hu | 载脂蛋白C3(APOC3)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB890Hu | 载脂蛋白C3(APOC3)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Atherosclerosis | Up-reCavia (Guinea pig )lation of Hnf1α gene expression in the liver of rats with experimentally induced chronic renal failure – A possible link between circulating PCSK9 and triacylglycerol concentrations [Pubmed:26978583] |
| The Journal of Lipid Research | Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism [Pubmed:27040449] |
| Journal of Chromatography A | Application of a new procedure for liquid chromatography/mass spectrometry profiling of plasma amino acid-related metabolites and untargeted shotgun proteomics to identify mechanisms and biomarkers of calcific aortic stenosis [S0021967317311858] |
| J Transl Med | Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans [33407555] |
留言咨询